Regenerative potential of muse cells in ROS-mediated cardiac injury: An in vitro oxygen-glucose deprivation/reoxygenation model.
Sallam A., Ibrahim Aly HS., El-Habachi NM., Elkafrawy H., Awaad A., Mehanna RA.
Laboratory Study on Cardiovascular Disease, published in Life Sci (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Life Sci (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42214608
- DOI
- 10.1016/j.lfs.2026.124498
Abstract (original English)
Myocardial Ischemia-reperfusion injury produces excessive reactive oxygen species, leading to myocardial cell death and debilitated cardiac function. The regenerative properties of cardiac stem/progenitor cells, particularly the Sca-1 + population, remain narrow under ischemia-reperfusion injury conditions. Multilineage stress-enduring cells known as Muse cells, a distinguished subpopulation of SSEA-3 + mesenchymal stromal cells (MSCs), have shown promise in tissue repair due to their stress-enduring, non-tumorigenic, and pluripotent-like properties. This study questioned the regenerative potential of Muse cells in rescuing Sca-1 + cardiac stem cells exposed in vitro to oxygen-glucose deprivation/reoxygenation injury. Muse cells were first isolated from human adipose mesenchymal stromal cells using Magnetic-activated cell sorting for SSEA-3 + cells. Co-culture experiments were conducted to assess the impacts of Muse cells on Sca-1 + cardiac stem cells proliferation, apoptosis, oxidative stress. Spontaneous Cardiac differentiation of Muse cells was assessed using expression of cardiac markers (GATA-4, Myosin light chain 2, Connexin-43, Troponin C1, and Myosin heavy chain 6. Muse cell co-culture with cells exposed to oxygen-glucose deprivation/reoxygenation injury significantly improved the survival and proliferation of Sca-1 + cardiac stem cells, while reducing apoptosis and oxi
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level AMeta-analysisEurope PMC
Can cell-based therapies bridge the gap between research and reality in the treatment of myocarditis? A systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
Regen Ther - Level AMeta-analysisEurope PMC
Efficacy and safety of stem cell therapy for myocardial infarction and heart failure: an updated systematic review and meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 3345 on Cardiovascular Disease, Stroke Research, published in Syst Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3345
Syst Rev - Level AMeta-analysisEurope PMC
Orally derived mesenchymal stem cells in the treatment of vascular diseases: a systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level ASystematic ReviewEurope PMC
From Preservation to Repair: A Systematic Review of Therapeutic Organ Rehabilitation During Normothermic Ex Vivo Machine Perfusion
Systematic Review with a reported sample of 12 on Cardiovascular Disease, Immune Modulation, published in Transplant Direct (2026) — summary generated from the PubMed abstract.
- 2026
- n = 12
Transplant Direct - Level AMeta-analysisEurope PMC
Safety and Efficacy of Transendocardial Stem Cells Therapy in Chronic Ischemic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis on Cardiovascular Disease, Stroke Research, published in Curr Cardiol Rev (2025) — summary generated from the PubMed abstract.
- 2025
Curr Cardiol Rev